A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors.
Cardio-oncology
Cardiotoxicity
Cardiovascular
Childhood cancer survivor
Journal
Cardio-oncology (London, England)
ISSN: 2057-3804
Titre abrégé: Cardiooncology
Pays: England
ID NLM: 101689938
Informations de publication
Date de publication:
06 Apr 2024
06 Apr 2024
Historique:
received:
14
12
2023
accepted:
15
02
2024
medline:
7
4
2024
pubmed:
7
4
2024
entrez:
6
4
2024
Statut:
epublish
Résumé
Cardiovascular complications related to cancer therapies are broad and variable in onset. These complications are the leading cause of non-cancer related morbidity and mortality in childhood cancer survivors and can also impact ongoing cancer treatment. Despite this understanding, dedicated cardio-oncology programs are lacking in pediatric cardiology. In an attempt to respond to these concerns, a risk-stratified, comprehensive cardio-oncology program was established to address the cardiovascular needs including prevention, early diagnosis, and management of patients with and at risk for cardiovascular complications of cancer therapy. This manuscript describes a single institution's experience of building and managing a multidisciplinary pediatric cardio-oncology program with close collaboration among cardiologists, oncologists, advanced cardiology and oncology practice providers, and allied health providers such as a dietitian and psychologist to provide comprehensive cardiovascular care for childhood cancer patients and survivors. In developing this program, emphasis was on the childhood cancer survivor population, as various cardiovascular complications can present many years after cancer treatment.
Identifiants
pubmed: 38582914
doi: 10.1186/s40959-024-00211-7
pii: 10.1186/s40959-024-00211-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
20Informations de copyright
© 2024. The Author(s).
Références
National Academies of Sciences, E., et al., in Childhood Cancer and Functional Impacts Across the Care Continuum, L. Aiuppa, et al., Editors et al. 2020, National Academies Press (US) Copyright 2021 by the National Academy of Sciences. All rights reserved.: Washington (DC).
Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014;14(1):61–70.
doi: 10.1038/nrc3634
pubmed: 24304873
Oeffinger KC, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82.
doi: 10.1056/NEJMsa060185
pubmed: 17035650
Lipshultz SE, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128(17):1927–95.
doi: 10.1161/CIR.0b013e3182a88099
pubmed: 24081971
Friend AJ, et al. Mental health of long-term survivors of childhood and young adult cancer: a systematic review. Int J Cancer. 2018;143(6):1279–86.
doi: 10.1002/ijc.31337
pubmed: 29468674
Chellapandian D, et al. Congestive heart failure among children with acute leukemia: a population-based matched cohort study. Leuk Lymphoma. 2019;60(2):385–94.
doi: 10.1080/10428194.2018.1474522
pubmed: 29966479
Armstrong GT, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31(29):3673–80.
doi: 10.1200/JCO.2013.49.3205
pubmed: 24002505
pmcid: 3804290
van der Pal HJ, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med. 2010;170(14):1247–55.
pubmed: 20660845
Armstrong GT, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(14):2328–38.
doi: 10.1200/JCO.2008.21.1425
pubmed: 19332714
pmcid: 2677921
Children’s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer Survivorship Guidelines. 2018 [cited 2018; Available from: http://www.survivorshipguidelines.org/pdf/2018/cog_ltfu_guidelines_v5.pdf .
Ehrhardt MJ, et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2023;24(3):e108–20.
doi: 10.1016/S1470-2045(23)00012-8
pubmed: 37052966
Ryan TD, et al. The landscape of cardiovascular care in pediatric cancer patients and survivors: a survey by the ACC Pediatric Cardio-Oncology Work Group. Cardiooncology. 2019;5:16.
pubmed: 32154022
pmcid: 7048086
Aziz-Bose R, et al. Delphi Panel Consensus Recommendations for Screening and Managing Childhood Cancer survivors at Risk for Cardiomyopathy. JACC CardioOncol. 2022;4(3):354–67.
doi: 10.1016/j.jaccao.2022.05.010
pubmed: 36213355
pmcid: 9537072
Kirk R, et al. The International Society for Heart and Lung Transplantation guidelines for the management of pediatric heart failure: executive summary. [Corrected]. J Heart Lung Transpl. 2014;33(9):888–909.
doi: 10.1016/j.healun.2014.06.002
Sacks N, Desai WE et al. S,., Oncology, hematopoietic transplant, and survivorship. The ASPEN Pediatric Nutrition Support Core Curriculum. 2nd ed, in The ASPEN Pediatric Nutrition Support Core Curriculum 2010. p. 349–377.
de Ferranti SD, et al. Cardiovascular Risk Reduction in High-Risk Pediatric patients: A Scientific Statement from the American Heart Association. Circulation. 2019;139(13):e603–34.
doi: 10.1161/CIR.0000000000000618
pubmed: 30798614
Belardo D, et al. Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic Cardiovascular Disease: an American Society for Preventive Cardiology Clinical Practice Statement. Am J Prev Cardiol. 2022;10:100323.
doi: 10.1016/j.ajpc.2022.100323
pubmed: 35284849
pmcid: 8914096
Bashore L, Hobbie W. Emerging and Ongoing Survivorship challenges among Childhood Cancer survivors and providing risk-based focused Follow-Up care. Semin Oncol Nurs. 2021;37(3):151163.
doi: 10.1016/j.soncn.2021.151163
pubmed: 34144848
Mertens L, et al. Multimodality Imaging for Cardiac Surveillance of Cancer Treatment in Children: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2023;36(12):1227–53.
doi: 10.1016/j.echo.2023.09.009
pubmed: 38043984
Lyon AR et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) Eur Heart J, 2022. 43(41): p. 4229–4361.
Plana JC, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014;27(9):911–39.
doi: 10.1016/j.echo.2014.07.012
pubmed: 25172399
Thavendiranathan P, et al. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25 Pt A):2751–68.
doi: 10.1016/j.jacc.2014.01.073
pubmed: 24703918
Neilan TG, et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013;111(5):717–22.
doi: 10.1016/j.amjcard.2012.11.022
pubmed: 23228924
Freyer DR. Transition of care for young adult survivors of childhood and adolescent cancer: rationale and approaches. J Clin Oncol. 2010;28(32):4810–8.
doi: 10.1200/JCO.2009.23.4278
pubmed: 20351333
pmcid: 3018346
Cardinale D, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981–8.
doi: 10.1161/CIRCULATIONAHA.114.013777
pubmed: 25948538
Tajiri K, Aonuma K, Sekine I. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients. Jpn J Clin Oncol. 2017;47(8):678–82.
doi: 10.1093/jjco/hyx068
pubmed: 28505345
Fradley MG, et al. Developing a Comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center Experience. Oncol Rev. 2017;11(2):340.
pubmed: 28781723
pmcid: 5523022
Austin-Mattison C. Joining forces: establishing a Cardio-Oncology Clinic. J Adv Pract Oncol. 2018;9(2):222–9.
pubmed: 30588356
pmcid: 6303000
Snipelisky D, et al. How to develop a Cardio-Oncology Clinic. Heart Fail Clin. 2017;13(2):347–59.
doi: 10.1016/j.hfc.2016.12.011
pubmed: 28279420
Lown EA, et al. Psychosocial Follow-Up in Survivorship as a Standard of Care in Pediatric Oncology. Pediatr Blood Cancer. 2015;62(Suppl 5):S514–84.
pubmed: 26700918
pmcid: 5242467
Recklitis CJ, Syrjala KL. Provision of integrated psychosocial services for cancer survivors post-treatment. Lancet Oncol. 2017;18(1):e39–e50.
doi: 10.1016/S1470-2045(16)30659-3
pubmed: 28049576
pmcid: 5865587
Hendriks MJ, et al. I don’t take for granted that I am doing well today: a mixed methods study on well-being, impact of cancer, and supportive needs in long-term childhood cancer survivors. Qual Life Res. 2022;31(5):1483–97.
doi: 10.1007/s11136-021-03042-6
pubmed: 34820777
Lubas MM, et al. The contribution of stress and distress to Cardiovascular Health in Adult survivors of Childhood Cancer. Cancer Epidemiol Biomarkers Prev. 2021;30(2):286–94.
doi: 10.1158/1055-9965.EPI-20-1183
pubmed: 33234555
Scialla MA et al. Delivery of care consistent with the psychosocial standards in pediatric cancer: current practices in the United States. Pediatr Blood Cancer, 2018. 65(3).
Patterson P, et al. The clinical utility of the adolescent and young adult psycho-oncology Screening Tool (AYA-POST): perspectives of AYA Cancer patients and Healthcare professionals. Front Psychol. 2022;13:872830.
doi: 10.3389/fpsyg.2022.872830
pubmed: 35602702
pmcid: 9120841